share_log

康寧傑瑞製藥-B：截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 6 03:33
Summary by Moomoo AI
康宁杰瑞制药-B（ALPHAMAB-B）於2024年2月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，法定/註冊股本結存為50,200美元，而已發行股份結存為964,843,807股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃一的股份期權數目有輕微減少，而首次公開發售後購股權計劃則新增了44,733,269股可發行的新股份。報告中未提及有關香港預託證券的資料，並確認所有證券發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
康宁杰瑞制药-B（ALPHAMAB-B）於2024年2月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，法定/註冊股本結存為50,200美元，而已發行股份結存為964,843,807股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃一的股份期權數目有輕微減少，而首次公開發售後購股權計劃則新增了44,733,269股可發行的新股份。報告中未提及有關香港預託證券的資料，並確認所有證券發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
CONNING GERRY PHARMACEUTICALS - B (ALPHAMAB-B) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF 31 JANUARY 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES WERE UNCHANGED DURING THE MONTH, WITH THE STATUTORY/REGISTERED SHARE CAPITAL OF $50,200 AND THE ISSUED SHARES DEPOSITED AT 964,843,807 SHARES. In addition, the number of stock options in the Company's stock option plan was slightly reduced in the number of share options under the Initial Public Offering Plan 1, and 44,733,269 new shares to be issued under the Initial Public Offering Option Plan. The report does not mention the information on the Hong Kong Pre-Trust Securities and confirms that all securities issues have been approved by the Board and comply with the requirements of the Listing Rules of the Hong Kong Stock Exchange Limited.
CONNING GERRY PHARMACEUTICALS - B (ALPHAMAB-B) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF 31 JANUARY 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES WERE UNCHANGED DURING THE MONTH, WITH THE STATUTORY/REGISTERED SHARE CAPITAL OF $50,200 AND THE ISSUED SHARES DEPOSITED AT 964,843,807 SHARES. In addition, the number of stock options in the Company's stock option plan was slightly reduced in the number of share options under the Initial Public Offering Plan 1, and 44,733,269 new shares to be issued under the Initial Public Offering Option Plan. The report does not mention the information on the Hong Kong Pre-Trust Securities and confirms that all securities issues have been approved by the Board and comply with the requirements of the Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more